Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
Crossref DOI link: https://doi.org/10.1007/s00280-016-3012-z
Published Online: 2016-03-26
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bryan, Jeffrey C.
Verstovsek, Srdan
License valid from 2016-03-26